Eisler Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3.47M Sell
78,300
-53,000
-40% -$2.48M 0.02% 412
2025
Q2
$6.08M Buy
131,300
+31,200
+31% +$1.53M 0.04% 354
2025
Q1
$6.1M Sell
100,100
-43,100
-30% -$2.51M 0.04% 404
2024
Q4
$8.14M Buy
+143,200
New +$8M 0.04% 343

Other funds holding BMY

Eisler Capital Management's BMY Position: Q3 2025 in Review

Eisler Capital Management increased its Bristol-Myers Squibb (BMY) stake by 100% in Q3 2025, buying an estimated $2.65M and bringing the position to 113,651 shares worth $5.04M. The position accounts for 0.02% of the portfolio, ranked #342.

Eisler Capital Management first reported a position in BMY in Q4 2024 and has held it in 4 quarters since. 2,268 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Eisler Capital Management held 113,651 shares of Bristol-Myers Squibb worth $5.04M as of Q3 2025.
  • Eisler Capital Management bought 56,819 Bristol-Myers Squibb shares in Q3 2025, an estimated $2.65M.
  • Bristol-Myers Squibb made up 0.02% of Eisler Capital Management's portfolio in Q3 2025, its #342 holding.
  • Eisler Capital Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 4 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Eisler Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.